tirzepatide/cyanocobalamin color An open letter from Eli Lilly and Company warning of potential patient safety risks associated with tirzepatide compounded with vitamin B12 Tirzepatide/B12 Injectable (68mg/8mg)

Microdosing GLP medication protocols: A personalized, gradual introduction using lower doses that allow your body to adapt comfortably

it is a dual GIP/GLP-1 receptor agonist that activates both GIP and GLP-1 receptors simultaneously

Patients who arrive at a new dose already well-hydrated and fiber-sufficient handle the transition significantly better than those who try to adjust after constipation has set in

Any nausea tends to peak 6-12 hours after injection

Integrating Tirzepatide into Your Post-Cancer Health Plan Starting tirzepatide as a breast cancer survivor requires coordination between your oncology team, primary care physician, and PlexusDx provider